Bringing the fundamentals into focus…
Back to Cytek Biosciences, Inc.
How Cytek Biosciences, Inc. stacks up
CTKB · against 480 other Healthcare companies of similar size
Overall
31/ 100
Near the bottom of its peers.
Ranked #399 of 481 · scores higher than 16% of peers
Bars: peers in each 10-point band of the overall score84 peers with an overall score of 30–39, including CTKB · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CTKB| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 3 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 4 | 7.5B CNY (≈$1.1B) | 82 | 72 | 64 | 96 | 0 / 2 | |
| 5 | 2.05T KRW (≈$1.5B) | 81 | 83 | 62 | 95 | 0 / 2 | |
| 390 | 534M USD | 32 | 8 | — | 13 | 0 / 2 | |
| 390 | 1.0B USD | 32 | 0 | — | 1 | 0 / 2 | |
| 390 | 705M USD | 32 | 8 | 20 | 7 | 0 / 2 | |
| 399 | 546M USD | 31 | 8 | 16 | 2 | 0 / 2 | |
| 399 | 775M USD | 31 | 8 | 34 | 24 | 1 / 2 | |
| 399 | 1.1B USD | 31 | 42 | — | 40 | 2 / 2 | |
| 399 | 643M USD | 31 | 8 | — | 16 | 0 / 2 | |
| 399 | 513M USD | 31 | 8 | 85 | 24 | 2 / 2 | |
| 404 | 6.7B CNY (≈$938M) | 30 | 43 | 10 | 50 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score